MeVis Medical Solutions AGFRA:M3V 66 FCF Yield % is 8.49 as of Jun. 30, 2026, which is 8% below its 10-year median of 9.22. GuruFocus rates FRA:M3V with a GF Score™ of 66/100 and a GF Value™ of €22.52. The stock has 4 warning signs investors should review. Among 684 Healthcare Providers & Services companies, MeVis Medical Solutions AG ranks better than 77.92% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for MeVis Medical Solutions AG's FCF Yield % or its related term are showing as below:
FRA:M3V'
s FCF Yield % Range Over the Past 10 Years
Min: 4.48 Med: 9.22 Max: 16.09
Current: 8.49
During the past 13 years, the highest FCF Yield % of MeVis Medical Solutions AG was 16.09%. The lowest was 4.48%. And the median was 9.22%.
FRA:M3V's FCF Yield % is ranked better than 77.92% of 684
companies
in the Healthcare Providers & Services industry
Industry Median: 1.92
vs FRA:M3V: 8.49
MeVis Medical Solutions AG FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
MeVis Medical Solutions AG FCF Yield % Related Terms
MeVis Medical Solutions AG FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:M3V vs VEEV, BTSG, TEM: FCF Yield % Comparison
For the Health Information Services subindustry, MeVis Medical Solutions AG's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MeVis Medical Solutions AG FCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's FCF Yield % distribution charts can be found below:
* The bar in red indicates where MeVis Medical Solutions AG's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MeVis Medical Solutions AG (FRA:M3V) has a FCF Yield % of 8.49 as of Jun. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on MeVis Medical Solutions AG and its competitors. This is near median its historical median of 9.22. Over the past decade, MeVis Medical Solutions AG's FCF Yield % has ranged from 4.48 to 16.09. According to the industry distribution chart, MeVis Medical Solutions AG ranks #151 out of 684 companies in the Healthcare Providers & Services industry, placing it in the top 22.1%.
Is MeVis Medical Solutions AG's FCF Yield % too high?
MeVis Medical Solutions AG's current FCF Yield % of 8.49 is near median its 10-year median of 9.22. Over the past 10 years, this metric has ranged from a low of 4.48 to a high of 16.09. The Healthcare Providers & Services industry median FCF Yield % is 1.92. MeVis Medical Solutions AG's value of 8.49 is 342.2% above this industry median. Based on the distribution chart, MeVis Medical Solutions AG ranks #151 out of 684 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, MeVis Medical Solutions AG has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does MeVis Medical Solutions AG's FCF Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MeVis Medical Solutions AG ranks #151 out of 684 companies for FCF Yield %. This places MeVis Medical Solutions AG in the top 22% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 1.92. MeVis Medical Solutions AG's value of 8.49 is 342.2% above this benchmark. Historically, MeVis Medical Solutions AG's own FCF Yield % has ranged from 4.48 to 16.09 over the past decade. While the company's 10-year median is 9.22 vs. the industry median of 1.92, MeVis Medical Solutions AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.92, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MeVis Medical Solutions AG's current FCF Yield % of 8.49 is 342.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on MeVis Medical Solutions AG and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MeVis Medical Solutions AG's current FCF Yield % is 8.49, which is near median its own 10-year median of 9.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MeVis Medical Solutions AG stock overvalued right now?
MeVis Medical Solutions AG (FRA:M3V) has a current FCF Yield % of 8.49. The stock's GF Value™ is €22.52, compared to a current price of €23.20 — trading 3% above its estimated fair value. The current FCF Yield % is 8.49, which is near median its 10-year median of 9.22 and 342.2% above the Healthcare Providers & Services industry median of 1.92. MeVis Medical Solutions AG's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For MeVis Medical Solutions AG (FRA:M3V), the current FCF Yield % is 8.49 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MeVis Medical Solutions AG (FRA:M3V) Overvalued in 2026?
Based on GuruFocus' analysis, MeVis Medical Solutions AG stock appears to be overvalued.
The current stock price of €23.20 is trading 3% above its estimated GF Value™ of €22.52.
Key valuation signals for FRA:M3V:
FCF Yield %: 8.49 (near median its 10-year median of 9.22)
GF Value™: €22.52 vs. price of €23.20 (3% above fair value)
Industry Position: 342.2% above the Healthcare Providers & Services median (#151 of 684)
No single metric tells the full story. See the FRA:M3V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
66GF Score
Get the complete analysis for FRA:M3V
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:M3V has been successfully added to your 
